Salta al contenuto principale
Passa alla visualizzazione normale.

Observational Trial [Patient Registry]

17-dic-2023

Ascolta
Study Title A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
NCT Number NCT01848561 Other IDs: P11-282
Conditions Ulcerative Colitis (UC)
Interventions  
Sponsor AbbVie
Sex ALL
Age ADULT, OLDER_ADULT
Phases  
Enrollment 8250
Study Type OBSERVATIONAL
Study Design Observational Model: |Time Perspective: 
Start Date 29/04/2013
Completion Date 24/06/2030
Locations Dott.ssa Maria Cappello, Gastroenterologia , Direttore Prof. Calogero Cammà, Azienda Ospedaliera Universitaria Paolo Giaccone /ID# 141397, Palermo, 90127, Italy| A.O. Ospedali Riuniti Villa Sofia - Cervello /ID# 141392, Palermo, 90146, Italy|
Study URL https://clinicaltrials.gov/study/NCT01848561 

  

Study Title AutoInflammatory Disease Alliance Registry (AIDA)
NCT Number NCT05200715 Other IDs: AIDA V.04 19.05.2021
Conditions Hereditary Autoinflammatory Diseases|Schnitzler Syndrome|Behcet Syndrome|PFAPA Syndrome|Still Disease|Autoinflammatory Syndrome, Unspecified|Uveitis|Scleritis|Vexas Syndrome
Interventions OTHER: No intervention is foreseen by the protocol.
Sponsor University of Siena
Sex ALL
Age CHILD, ADULT, OLDER_ADULT
Phases  
Enrollment 3500
Study Type OBSERVATIONAL
Study Design Observational Model: |Time Perspective: 
Start Date 08/06/2020
Completion Date 08/06/2030
Locations ARNAS Ospedale Civico di Cristina Benfratelli, Palermo, Italy| Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy| prof.ssa Maria Cristina Maggio, University Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”, University of Palermo, Palermo, Italy|
Study URL https://clinicaltrials.gov/study/NCT05200715 

 

Title LOWER: Lomitapide Observational Worldwide Evaluation Registry
NCT Number NCT02135705
AEGR-733-025
Conditions Homozygous Familial Hypercholesterolemia
Interventions Parallel Assignment
Sponsor Amryt Pharma
Gender All
Age Child, Adult, Older Adult
Phases  
Enrollment 300
Study Type Observational [Patient Registry]
Study Designs Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Start Date 18/03/2014
Completion Date 01/09/2028
Locations A.O.U. Policlinico P. Giaccone di Palermo, Prof. Angelo Baldassare Cefalù, Principal Investigator
URL https://clinicaltrials.gov/ct2/show/NCT02135705 

 

Title Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY): A GIMEMA Observational Registry for Italian MPN Patients
NCT Number NCT04378855
QoL MPN0118
Conditions Myeloproliferative Neoplasm
Other: Questionnaire
Interventions  
Sponsor Gruppo Italiano Malattie EMatologiche dell'Adulto
Gender All
Age 18 Years and older (Adult, Older Adult)
Phases Phase 2
Enrollment 576 participants
Study Type Observational
Study Designs Cohort
Start Date 30/09/2020
Completion Date 31/10/2026
Locations A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. di Ematologia, Prof. Sergio Siragusa
URL https://www.clinicaltrials.gov/ct2/show/NCT04378855 

  

Title HoFH, the International Clinical Collaborators - A Global HoFH Data-sharing Platform
NCT Number NCT04815005
HICC
Conditions Homozygous Familial Hypercholesterolemia
Interventions Parallel Assignment
Sponsor University of Pennsylvania
Gender All
Age Child, Adult, Older Adult
Phases  
Enrollment 1000 participants
Study Type Observational [Patient Registry]
Study Designs Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Start Date 24/01/2017
Completion Date 31/12/2025
Locations A.O.U. Policlinico P. Giaccone di Palermo, Prof. Maurizio Averna, Prof. Angelo Baldassare Cefalù
URL https://clinicaltrials.gov/ct2/show/NCT04815005
https://www.centerwatch.com/clinical-trials/listings/270143/hofh-the-international-clinical-collaborators-registry/   

 

Title Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
NCT Number NCT04298892
Conditions Intervention/treatment 

Haematologic Disease

Haematological Malignancy

Other: clinical data and sample collection
Interventions  
Sponsor Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Gender All
Age 18 Years and older   (Adult, Older Adult)
Phases  
Enrollment 2000 participants
Study Type Observational [Patient Registry]
Study Designs Cohort
Start Date 07/01/2020
Completion Date 01/02/2025
Locations A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. di Ematologia, Prof. Sergio Siragusa
URL https://www.clinicaltrials.gov/ct2/show/NCT04298892 

 

Title Epidemiology of COVID-19 Infection in Patients With Hematological Malignancies: A European Haematology Association Survey
NCT Number NCT04733729
Conditions COVID-19 Infection in Hematological Malignancies Patients
Interventions  
Sponsor LIVIO PAGANO, Catholic University of the Sacred Heart
Gender All
Age 18 Years to 99 Years   (Adult, Older Adult)
Phases  
Enrollment 3000 participants
Study Type Observational [Patient Registry]
Study Designs Cohort
Start Date 01/03/2020
Completion Date 31/03/2024
Locations A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. di Ematologia, Prof. Sergio Siragusa, Dott.ssa Mitra
URL https://www.clinicaltrials.gov/ct2/show/NCT04733729 

 

Title Retro-prospective Observational Study on Risk of Progression in Chronic Phase-Chronic Myeloid Leukemia Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation (TFR - PRO)
NCT Number NCT04621851
TFR-PRO
Conditions Chronic Myeloid Leukemia
Interventions  
Sponsor CARLO GAMBACORTI PASSERINI, University of Milano Bicocca
Gender All
Age 18 Years and older   (Adult, Older Adult)
Phases  
Enrollment 3000 participants
Study Type Observational [Patient Registry]
Study Designs Cohort
Start Date 30/09/2020
Completion Date 30/09/2023
Locations A.O.U. Policlinico P. Giaccone di Palermo, U.O.C. di Ematologia, Prof. Sergio Siragusa,  dott. Accurso
URL https://www.clinicaltrials.gov/ct2/show/NCT04621851 

 

Title Italian adult Immune ThrombocytoPenia (ITP) Registry Investigation on a Dynamic Cohort of Italian Patients With Active ITP
NCT Number NCT03465020
Conditions Intervention/treatment 

Idiopathic Thrombocytopenic Purpura

Other: Observation
Interventions  
Sponsor Gruppo Italiano Malattie EMatologiche dell'Adulto
Gender All
Age 18 Years and older (Adult, Older Adult)
Phases  
Enrollment 861 participants
Study Type Observational [Patient Registry]
Study Designs Cohort
Start Date 15/10/2018
Completion Date 01/07/2023
Locations A.O.U. Policlinico P. Giaccone di Palermo  - UO Ematologia, Prof. Sergio Siragusa 
URL https://www.clinicaltrials.gov/ct2/show/NCT03465020